AbbVie Q4 2024 Earnings Preview: Strong results expected on Skyrizi, Rinvoq growth trajectory

AbbVie (NYSE:ABBV) is scheduled to announce Q4 earnings results on Friday, January 31st, before market open.

Analysts expect profit of $2.31 per share, a fall of 17.2% Y/Y on revenue of $14.82B, up 3.6% Y/Y.

According to SA analyst ONeil